News & Events

News &
Events

Tarsier Pharma to Present at Ophthalmology Futures Retina Forum 2024

September 18, 2024

Tarsier Pharma, Ltd. is thrilled to announce its participation in the Ophthalmology Futures Retina Forum 2024, set to take place on Wednesday, September 18, at the Esferic in Barcelona, Spain. Dr. Daphne Haim-Langford, CEO and Chairperson of Tarsier Pharma, will present our corporate deck, providing insights into our latest advancements and strategic vision toward the TRS02, intravitreal slow-release formulation of dazdotuftide for the treatment of blinding retinal diseases.

The Ophthalmology Futures Retina Forum is a premier gathering that brings together clinicians, scientists, regulators, and business leaders to discuss the latest developments and trends in retinal disease management. The discussions and insights generated from this forum have the potential to shape the future of retinal disease treatment and innovation.

We look forward to contributing to this significant event and sharing our expertise with the global ophthalmology community.

About Tarsier Pharma

Tarsier Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat immune-mediated blinding diseases in the front and back of the eye.

Contact:

Investor Relations Tarsier Pharma

[email protected]

Scroll to Top